Scholarlink

Introduction and Objective <p>Chewable gels (CGs) offer a promising alternative for oral drug administration when swallowing solid dosage forms becomes an issue, particularly in pediatric and geriatric populations or patients with dysphagia. In recent years, most CGs formulations have focused on immediate drug release mechanisms, primarily developed using gelatin. This study focuses on the development of CGs, based on plant-based materials (i.e., sodium alginate), intended for sustained drug release.&#xa0;</p> Methods <p>Different calcium sources and sequestering agents were evaluated to optimize the gelation process, and the most promising combination was used to incorporate drugs with different aqueous solubility profiles (losartan potassium and amiodarone). The suitability of alginate-based CGs as a sustained drug-release system was assessed by in vitro dissolution profiles, in comparison with immediate-release formulations (gelatin-based CGs, specifically developed for this purpose, and commercial tablets).</p> Results <p>The obtained CGs exhibited acceptable organoleptic, mechanical, and microbiological properties, and adequate results for pH (between 3.0 and 5.0), water activity (lower than 0.65), syneresis (lower than 35%), and drug content (between 94.1 and 102.4% of theoretical amount). In vitro dissolution study showed a typical sustained-release profile, reaching around a 100% dissolved for losartan and 85% for amiodarone after 24&#xa0;h.</p> Conclusion <p>In conclusion, alginate-based CGs were successfully developed and characterized, demonstrating significant potential as a sustained-release oral drug delivery system that could enhance treatment adherence in specific populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Innovative Alginate-based Chewable Gels for Sustained Oral Drug Delivery

  • 期刊论文

  • 发表日期：

    2025年10月20日

查看全文
  • Romina Belén Pereyra,
  • Milagros Salomé Tosto,
  • Noelia Luján Gonzalez Vidal

摘要

Introduction and Objective

Chewable gels (CGs) offer a promising alternative for oral drug administration when swallowing solid dosage forms becomes an issue, particularly in pediatric and geriatric populations or patients with dysphagia. In recent years, most CGs formulations have focused on immediate drug release mechanisms, primarily developed using gelatin. This study focuses on the development of CGs, based on plant-based materials (i.e., sodium alginate), intended for sustained drug release. 

Methods

Different calcium sources and sequestering agents were evaluated to optimize the gelation process, and the most promising combination was used to incorporate drugs with different aqueous solubility profiles (losartan potassium and amiodarone). The suitability of alginate-based CGs as a sustained drug-release system was assessed by in vitro dissolution profiles, in comparison with immediate-release formulations (gelatin-based CGs, specifically developed for this purpose, and commercial tablets).

Results

The obtained CGs exhibited acceptable organoleptic, mechanical, and microbiological properties, and adequate results for pH (between 3.0 and 5.0), water activity (lower than 0.65), syneresis (lower than 35%), and drug content (between 94.1 and 102.4% of theoretical amount). In vitro dissolution study showed a typical sustained-release profile, reaching around a 100% dissolved for losartan and 85% for amiodarone after 24 h.

Conclusion

In conclusion, alginate-based CGs were successfully developed and characterized, demonstrating significant potential as a sustained-release oral drug delivery system that could enhance treatment adherence in specific populations.